Suchergebnisse - "García Layana, Alfredo"

PubPharm (18)

1

Macular Neovascularization Type Influence on Anti-VEGF Intravitreal Therapy Outcomes in Age-Related Macular Degeneration

enthalten in: Ophthalmology. Retina | 2024

von Izquierdo-Serra, J. | Martin-Pinardel, R. | Moll-Udina, A. | +123

2

Efficacy, durability, and safety of intravitreal faricimab up to every 16 weeks for neovascular age-related macular degeneration (TENAYA and LUCERNE) : two randomised, double-masked, phase 3, non-inferiority trials

enthalten in: Lancet (London, England) | 2022

von Heier, J. | Khanani, A. | Quezada Ruiz, C. | +115

CommentIn: Lancet. 2022 Feb 19;399(10326):697-699. - PMID 35085501

3

Role of intraretinal and subretinal fluid on clinical and anatomical outcomes in patients with neovascular age-related macular degeneration treated with bimonthly, treat-and-extend and as-needed ranibizumab in the In-Eye study

enthalten in: Acta ophthalmologica | 2021

von Saenz-de-Viteri, M. | Recalde, S. | Fernandez-Robredo, P. | +44

4

Bimonthly, treat-and-extend and as-needed ranibizumab in naïve neovascular age-related macular degeneration patients : 12-month outcomes of a randomized study

enthalten in: Acta ophthalmologica | 2020

von López Gálvez, M. | Arias Barquet, L. | S Figueroa, M. | +31

5

First-line treatment algorithm and guidelines in center-involving diabetic macular edema

enthalten in: European journal of ophthalmology | 2019

von Kodjikian, L. | Bellocq, D. | Bandello, F. | +10

6

In vivo effect of bevacizumab-loaded albumin nanoparticles in the treatment of corneal neovascularization

enthalten in: Experimental eye research | 2019

von Luis de Redín, I. | Boiero, C. | Recalde, S. | +5

7

Association between CFH, CFB, ARMS2, SERPINF1, VEGFR1 and VEGF polymorphisms and anatomical and functional response to ranibizumab treatment in neovascular age-related macular degeneration

enthalten in: Acta ophthalmologica | 2018

von Cobos, E. | Recalde, S. | Anter, J. | +11

8

Single- and repeated-dose toxicity study of bevacizumab, ranibizumab, and aflibercept in ARPE-19 cells under normal and oxidative stress conditions

enthalten in: Biochemical pharmacology | 2016

von Saenz-de-Viteri, M. | Fernández-Robredo, P. | Hernández, M. | +4

9

INTRAVITREAL ANTI-VASCULAR ENDOTHELIAL GROWTH FACTOR THERAPY FOR CHOROIDAL NEOVASCULARIZATION SECONDARY TO PATHOLOGIC MYOPIA : SIX YEARS OUTCOME

enthalten in: Retina (Philadelphia, Pa.) | 2015

von Ruiz-Moreno, J. | Montero, J. | Araiz, J. | +5

CommentIn: Retina. 2016 Jun;36(6):e50-1. - PMID 27145253

10

Treatment of Exudative Age-related Macular Degeneration : Focus on Aflibercept

enthalten in: Drugs & aging | 2015

von García-Layana, A. | Figueroa, M. | Araiz, J. | +4